ADS-5102 Aided Walking Speed in Select MS Patients in INROADS Trial & It’s Flu Vaccine Time Again

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about a how a Phase 3 trial analysis showed ADS-5102 significantly increased walking speed in 21% MS patients with difficulties; further work stopped.Also, Price Wooldridge reads “It’s Flu Vaccine Time Again, So Here’s What You Need to Know”, a column by Ed Tobias.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/